Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neuroendocrine Tumors 3Lung Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neural crest tumor 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Liver Neoplasms 1Liver Malignancy 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5Iodine-131 3Fluorodeoxyglucose F18 3trametinib 2pazopanib 2belinostat 2Vemurafenib 2Trastuzumab 2Specimen Handling 2Sirolimus 2Paclitaxel 2Fluorouracil 2FAPI-46 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Biopsy 2Bevacizumab 2Azacitidine 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1romidepsin 1pembrolizumab 1naporafenib 1mercaptoundecahydrododecaborate 1fludarabine phosphate 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Thyroid Neoplasms × Positron Emission Tomography Computed Tomography × Clear all
NCT03647358 2026-04-14

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
60 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡